Tan et al. developed a PEGylated anti-MUC1 aptamer-DOX complex for targeted drug delivery to breast cancer cells, demonstrating the macrophage evasion of drug could be decreased by PEGylation. This evidence concerns the gene MUC1 and breast cancer.